Search results
TauRx Submits UK Marketing Authorisation Application for HMTM as a Treatment for Alzheimer's Disease
Financial Post· 2 days agoAuthorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive impairment (MCI-AD) and mild to moderate stages ...
Silent Killer Unmasked: 28% of “Healthy” Seniors Have Undiagnosed Heart Valve Disease
SciTechDaily· 6 days agoA study identified undiagnosed heart valve disease in 28% of people over 60, emphasizing the...